Clinical Trials Sponsored by David Loeb

Total 1843 results

Mark Loeb

Not yet recruiting

Fourth Dose of mRNA COVID-19 Vaccine in Residents of LTCFs

Coronavirus Infection | SARS-CoV2 Infection

Canada
David P. Richman, MD
Jacobus Pharmaceutical

No longer available

Treatment of Lambert-Eaton Syndrome With 3,4 DAP

Lambert Eaton Myasthenic Syndrome

United States
David Lynch Foundation

Not yet recruiting

Transcendental Meditation and PTSD

Suicidal Ideation | Depressive Symptoms | Alcohol Use, Unspecified | Ptsd
Robert Davis
Davis EyeCare

Completed

"Night Vision and Carotenoids"

Macular Degeneration

United States
Bausch & Lomb Incorporated

Recruiting

Study of Safety and Effectiveness of the Boston Orthokeratology Shaping Lens in the Arise Orthokeratology Lens

Astigmatism

United States
Bausch & Lomb Incorporated

Recruiting

Safety and Effectiveness of the TENEO 317 Model 2 (1.28 US) Excimer Laser for Laser In Situ Keratomileusis (LASIK) Surgery to Treat Hyperopia With or Without Astigmatism

Hyperopia

United States
Bausch & Lomb Incorporated

Completed

Ketotifen/Naphazoline Ophthalmic Solution in the Conjunctival Allergen Challenge Model of Allergic Conjunctivitis.

Allergic Conjunctivitis

United States
Bausch & Lomb Incorporated

Completed

Safety and Efficacy of Different Add Powers With a New Presbyopic Lasik Treatment Algorithm

Ametropia

Philippines
Bausch & Lomb Incorporated

Completed

Orientation Characteristics of Kalifilcon A Daily Disposable Toric Contact Lenses Compared to Acuvue Oasys 1-Day for Astigmatism Contact Lenses

Astigmatism

United States
Bausch & Lomb Incorporated

Completed

Evaluation of the Safety and Pharmacokinetics of Brimonidine Tartrate 0.025%/Ketotifen Fumarate 0.035% Combination Ophthalmic Solution

Allergic Conjunctivitis

United States
Bausch & Lomb Incorporated

Completed

Therapeutic Equivalence Study of Generic Brinzolamide vs Azopt

Glaucoma | Open Angle or Ocular Hypertension

United States
Bausch & Lomb Incorporated

Completed

A Study of B + L Ophthalmic Viscosurgical Device (OVD) CVisc50

Cataract

United States
Bausch & Lomb Incorporated

Completed

1-Week Dispensing Evaluation of Kalifilcon A Toric Contact Lenses Compared to Ultra for Astigmatism

Astigmatism | Myopia

United States
Bausch & Lomb Incorporated

Completed

Insertion Clinical Study to Evaluate the Aberration Characteristics of Kalifilcon A Toric Lenses

Contact Lens Wearer

United States
Bausch & Lomb Incorporated

Completed

Product Performance of a New Silicone Hydrogel Contact Lens

Myopia

United States
Bausch & Lomb Incorporated

Completed

LE Gel for the Treatment of Ocular Inflammation and Pain Following Cataract Surgery

Pain | Ocular Inflammation | Cataract

United States
Bausch & Lomb Incorporated

Completed

Clinical Study of Approved Contact Lenses

Myopia

United States
Bausch & Lomb Incorporated

Completed

A Study to Evaluate the Performance of Two Designs of Soft Toric Lenses

Myopia

United States
Bausch & Lomb Incorporated

Completed

Evaluation of Two Different Designs of Bausch & Lomb Contact Lenses

Myopia

United States
Bausch & Lomb Incorporated

Completed

Bepotastine Besilate Nasal Sprays in the Treatment of Seasonal Allergic Rhinitis (SAR)

Seasonal Allergic Rhinitis

United States
Bausch & Lomb Incorporated

Completed

Hydrophobic Acrylic Toric IOL Designed to Reduce the Effects of Preoperative Corneal Astigmatism

Astigmatism

United States
Bausch & Lomb Incorporated

Completed

A Phase 2, Dose Finding Study of PF-03187207 in Patients With Primary Open Angle Glaucoma or Ocular Hypertension.

Primary Open Angle Glaucoma | Ocular Hypertension

Japan
Bausch & Lomb Incorporated

Completed

Safety and Efficacy of Bepotastine Besilate Ophthalmic Solution in Seasonal Allergic Conjunctivitis Patients

Allergic Conjunctivitis

United States
Bausch & Lomb Incorporated

Completed

A Dose Ranging Study to Evaluate Safety and Efficacy of Bromfenac Ophthalmic Solution in Dry Eye Disease

Dry Eye Syndrome

United States
Bausch & Lomb Incorporated

Completed

Mapracorat Ophthalmic Formulation in Subjects With Allergic Conjunctivitis

Conjunctivitis, Allergic

United States
Bausch & Lomb Incorporated

Terminated

Mapracorat Ophthalmic Suspension, 3% for the Treatment of Ocular Inflammation Following Cataract Surgery

Pain | Inflammation | Cataract

United States
Bausch & Lomb Incorporated

Completed

Mapracorat Ophthalmic Suspension, 3% for the Treatment of Ocular Inflammation and Pain Following Cataract Surgery

Inflammation | Cataract | Surgery

United States
Bausch & Lomb Incorporated

Completed

Ocular Responses to Short and Long-term Lens Wear

Ametropia

Canada
Bausch & Lomb Incorporated

Completed

A Study to Evaluate the Safety and Efficacy of Lotemax Ophthalmic Suspension 0.5%

Inflammation | Conjunctivitis, Seasonal Allergic | Conjunctivitis, Giant Papillary

Korea, Republic of
Bausch & Lomb Incorporated

Completed

A Study to Evaluate the Product Performance of a New Silicone Hydrogel Contact Lens

Myopia

United States
Bausch & Lomb Incorporated

Completed

Long-Term Safety of Latanoprostene Bunod Ophthalmic Solution 0.024% in Japanese Subjects With OAG or OHT (JUPITER)

Ocular Hypertension | Glaucoma

United States
Bausch & Lomb Incorporated

Completed

Evaluation of the Safety, Systemic Pharmacokinetics, and Tolerability of Single and Repeat Ocular Installations

Healthy

United States
Bausch & Lomb Incorporated

Completed

Safety and Efficacy of Zylet vs Lotemax, Tobramycin and Vehicle in Pediatric Blepharoconjunctivitis

Conjunctivitis

United States
Bausch & Lomb Incorporated

Completed

Loteprednol Etabonate Ophthalmic Ointment vs. Vehicle in the Treatment of Inflammation Following Cataract Surgery

Ocular Inflammation

United States
Bausch & Lomb Incorporated

Completed

Loteprednol Etabonate in an Ophthalmic Base vs Vehicle for the Treatment of Inflammation Following Cataract Surgery

Ocular Inflammation

United States
Bausch & Lomb Incorporated

Completed

A Study to Investigate the Safety and Efficacy of BOL-303224 in the Treatment of Bacterial Conjunctivitis

Acute Bacterial Conjunctivitis
Bausch & Lomb Incorporated

Completed

Evaluation of a New Silicone Hydrogel Contact Lens

Myopia

United States
Bausch & Lomb Incorporated

Completed

A Study to Evaluate the Safety and Efficacy of a New Silicone Hydrogel Contact Lens Design

Myopia
Bausch & Lomb Incorporated

Terminated

Twelve Month Clinical Evaluation of KeraSoft IC Soft Contact Lenses

Keratoconus

United States
Bausch & Lomb Incorporated

Completed

Efficacy of Bromfenac Ophthalmic Solution in Patients Undergoing Cataract Surgery

Pain | Inflammation | Cataract

United States
Bausch & Lomb Incorporated

Completed

Feasibility of a New Silicone Hydrogel Lens

Myopia

United States
Bausch & Lomb Incorporated

Completed

Product Feasibility of a New Silicone Hydrogel Contact Lens

Myopia

United States
Bausch & Lomb Incorporated

Completed

Evaluation of 3 Intraocular Lenses Following Lens Extraction

Cataract

United States
Bausch & Lomb Incorporated

Terminated

Evaluation of the Safety and Effectiveness of the Akreos MI Five-0 Intraocular Lens.

Cataract

Germany
Bausch & Lomb Incorporated

Completed

A Clinical Evaluation of the Next Generation Diagnostic Instrument (NGDI)

Healthy

United States
Bausch & Lomb Incorporated

Completed

Safety and Efficacy of a Contact Lens for Daily Disposable Use

Myopia

United States
Bausch & Lomb Incorporated

Completed

A Study to Assess the Safety and Efficacy of a Daily Disposable Contact Lens

Myopia

United States
Bausch & Lomb Incorporated

Completed

Corneal Endothelial Cell Density Changes, When Mapracorat Ophthalmic Suspension 3%, is Administered for 14 Days

Corneal Endothelial Cell Changes

United States
Bausch & Lomb Incorporated

Completed

Tear Fluid Levels of Loteprednol Etabonate Ophthalmic Gel 0.5% Following a Single Instillation

Pharmacokinetics

United States
Bausch & Lomb Incorporated

Withdrawn

A Study to Evaluate the Performance and Safety of Artelac Rebalance® Versus Vismed in the Management of Dry Eye

Dry Eye

3

Subscribe